{"log_id": 2292474238005848950, "direction": 0, "words_result_num": 28, "words_result": [{"probability": {"variance": 1.1e-05, "average": 0.996954, "min": 0.990297}, "location": {"width": 142, "top": 207, "height": 33, "left": 146}, "words": "[老年用药]"}, {"probability": {"variance": 2.7e-05, "average": 0.99658, "min": 0.978252}, "location": {"width": 458, "top": 244, "height": 45, "left": 178}, "words": "老年患者使用本品与成年人一样(见“药代动力学”)"}, {"probability": {"variance": 0.000809, "average": 0.987689, "min": 0.912499}, "location": {"width": 194, "top": 334, "height": 42, "left": 150}, "words": "[药物相互作用]"}, {"probability": {"variance": 4.4e-05, "average": 0.996201, "min": 0.9714}, "location": {"width": 816, "top": 363, "height": 57, "left": 179}, "words": "用ACE抑制剂患者应避免与保钾利尿剂(如螺内酯、氨苯喋啶及阿米洛利等药)合用,以及避"}, {"probability": {"variance": 2.2e-05, "average": 0.997526, "min": 0.976951}, "location": {"width": 843, "top": 404, "height": 55, "left": 151}, "words": "免补钾或补含钾的电解质溶液,因为这可能导致血清钾显著增加。若必须合用,则应密切监测血清"}, {"probability": {"variance": 0, "average": 0.999462, "min": 0.999462}, "location": {"width": 22, "top": 472, "height": 24, "left": 152}, "words": "钾"}, {"probability": {"variance": 4e-06, "average": 0.99907, "min": 0.987296}, "location": {"width": 799, "top": 483, "height": 53, "left": 180}, "words": "服用ACE抑制剂且同时接受带锂治疗的病人中有报告称血清锂浓度上升和发现锂中毒的症状"}, {"probability": {"variance": 6e-06, "average": 0.998734, "min": 0.987648}, "location": {"width": 834, "top": 523, "height": 50, "left": 152}, "words": "因此对于上述合并治疗需谨慎对待,建议经常性地检测血清中的锂浓度。如果同时使用了利尿剂"}, {"probability": {"variance": 1.2e-05, "average": 0.997839, "min": 0.985912}, "location": {"width": 297, "top": 576, "height": 36, "left": 152}, "words": "发生锂中毒的风险可能会有所上升"}, {"probability": {"variance": 0.000105, "average": 0.996142, "min": 0.939764}, "location": {"width": 815, "top": 599, "height": 51, "left": 184}, "words": "已经发现在和消炎痛同时使用时,ACE抑制剂的抗高血压疗效会被降低。但是在一次对照的临"}, {"probability": {"variance": 0.005579, "average": 0.982048, "min": 0.61669}, "location": {"width": 483, "top": 648, "height": 41, "left": 153}, "words": "床试验中,消炎痛并没有影响到洛汀新”的抗高血压疗效"}, {"probability": {"variance": 0.001518, "average": 0.989443, "min": 0.76508}, "location": {"width": 815, "top": 678, "height": 47, "left": 184}, "words": "本品与β-阻滞剂、钙拮抗剂、西咪替丁、利尿剂、地高辛、肼苯哒嗪、华法林、双香豆素,阿"}, {"probability": {"variance": 0.001401, "average": 0.989915, "min": 0.815281}, "location": {"width": 845, "top": 716, "height": 50, "left": 156}, "words": "司匹林及茶普生合用,临床未见明显不良相互作用。用利尿剂或体液不足者,用ACE抑制剂治疗初"}, {"probability": {"variance": 0.000255, "average": 0.993603, "min": 0.900235}, "location": {"width": 826, "top": 755, "height": 48, "left": 155}, "words": "期,偶有血压过低。提前停用利尿剂2-3日,再开始本品治疗,可减轻低血压。(见“用法用量"}, {"probability": {"variance": 0.000449, "average": 0.993037, "min": 0.89155}, "location": {"width": 809, "top": 793, "height": 49, "left": 155}, "words": "和“注意事项”)。增加血浆肾素活性或改变钠平衡的药物可增强本品的降压作用(如利尿剂)"}, {"probability": {"variance": 1.6e-05, "average": 0.995693, "min": 0.988579}, "location": {"width": 140, "top": 888, "height": 32, "left": 157}, "words": "[药物过量]"}, {"probability": {"variance": 0, "average": 0.99951, "min": 0.999052}, "location": {"width": 101, "top": 939, "height": 27, "left": 186}, "words": "症状和体征"}, {"probability": {"variance": 9e-06, "average": 0.998028, "min": 0.985382}, "location": {"width": 519, "top": 965, "height": 39, "left": 185}, "words": "虽未有本品过量的先例,但主要的症状可能是明显的低血压"}, {"probability": {"variance": 0, "average": 0.999645, "min": 0.999578}, "location": {"width": 42, "top": 1018, "height": 24, "left": 186}, "words": "处理"}, {"probability": {"variance": 5.2e-05, "average": 0.996576, "min": 0.962127}, "location": {"width": 823, "top": 1034, "height": 49, "left": 184}, "words": "若服药后不久,则应催吐,尽管其活性代谢物贝那普利拉只能少量透析,对于严重肾功能受损"}, {"probability": {"variance": 0.000549, "average": 0.994679, "min": 0.858493}, "location": {"width": 720, "top": 1077, "height": 47, "left": 154}, "words": "的病人,透析仍可作为正常消除的辅助方法。血压显著降低时,应静注生理盐水"}, {"probability": {"variance": 1.1e-05, "average": 0.997379, "min": 0.990809}, "location": {"width": 139, "top": 1169, "height": 31, "left": 159}, "words": "[药理毒理]"}, {"probability": {"variance": 3.8e-05, "average": 0.99709, "min": 0.963506}, "location": {"width": 821, "top": 1202, "height": 45, "left": 186}, "words": "本品是一种前体药,水解后成活性物质贝那普利拉,可抑制血管紧张素转换酶(ACE),阻止血"}, {"probability": {"variance": 0.002679, "average": 0.9849, "min": 0.667219}, "location": {"width": 853, "top": 1240, "height": 48, "left": 156}, "words": "管紧张素I转化成血管紧张素II。这样就可以减少由于血管紧张素II而引发的一系列症状,即血"}, {"probability": {"variance": 0.000201, "average": 0.995286, "min": 0.911709}, "location": {"width": 852, "top": 1280, "height": 47, "left": 157}, "words": "管收缩和生成醛固酮(后者将导致肾小管对钠和水的重吸收以及提高心输出血量)。洛汀新减少血"}, {"probability": {"variance": 0, "average": 0.999535, "min": 0.997687}, "location": {"width": 382, "top": 1330, "height": 37, "left": 158}, "words": "管舒张导致的反射性交感兴奋性的心率加快"}, {"probability": {"variance": 8e-06, "average": 0.995992, "min": 0.992335}, "location": {"width": 61, "top": 1378, "height": 23, "left": 190}, "words": "高血压"}, {"probability": {"variance": 0.049815, "average": 0.885016, "min": 0.438662}, "location": {"width": 143, "top": 1358, "height": 44, "left": 978}, "words": "质量管理"}], "language": 3}